Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medipharm Labs Corp
T.LABS
Alternate Symbol(s):
MEDIF
Healthcare
Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,...
packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:LABS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
...
Next
(615)
•••
okgonow
X
View Profile
View Bullboard History
Post by
okgonow
on Feb 15, 2024 12:38pm
wow
that didnt take you guys long to complain .... cant take a little lighthearted ribbing !!!! Mommy he said a bad word !!!....lol
(4)
•••
2busy2
X
View Profile
View Bullboard History
Post by
2busy2
on Feb 15, 2024 12:14pm
subaru1 - are we a little cracked -
or what ?????????????????????????????????
(137)
•••
subaru1
X
View Profile
View Bullboard History
Comment by
subaru1
on Feb 15, 2024 11:39am
RE:RE:So, now we know subaru1i has at least 3 accounts
I got the same feeling
(80)
•••
Starkicker
X
View Profile
View Bullboard History
Comment by
Starkicker
on Feb 15, 2024 11:29am
RE:So, now we know subaru1i has at least 3 accounts
S1i, alleyesonme, and MDJBrown, and maybe 1hottechwoman are all the same person. Ignore them. Everything they say is BS. This stock is going nowhere.
(56)
•••
unplugged1
X
View Profile
View Bullboard History
Post by
unplugged1
on Feb 15, 2024 11:04am
So, now we know subaru1i has at least 3 accounts
..nobody every likes 'imaginations' posts' otherwise. prove me wrong, everyone who liked his latest post say I..?
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Feb 14, 2024 2:21pm
Pfizer has to stand tall and protect their research with LAB
and not allow anyone else to buy them. Take a look while you still have time on the research Pfizer conducted on cannabinoid pharmaceuticals years ago. Then came Medipharm
...more
(56)
•••
Redwine12345
X
View Profile
View Bullboard History
Comment by
Redwine12345
on Feb 14, 2024 2:17pm
RE:RE:Financial
Not necessarily. Economy of scale, variable costs, capacity constraints, and opportunity costs are all factors that could make a big difference if revenue increases. For this stock to fly
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Comment by
subaru1i
on Feb 14, 2024 2:13pm
RE:RE:RE:Who will know first? Well look at the government as a
This is NOT at all about rescheduling for recreational. The request came from the White House, FDA, and NIH so it IS all about the pharmaceutical applications. Matter a fact,
...more
(56)
•••
unplugged1
X
View Profile
View Bullboard History
Comment by
unplugged1
on Feb 14, 2024 12:52pm
RE:Financial
the decrease in loss hopefully pending is far more important than the revenue appreciation for greater stockprice movement. Even if the revenue is incremental, if the loss narrows by a greater
...more
(56)
•••
unplugged1
X
View Profile
View Bullboard History
Post by
unplugged1
on Feb 14, 2024 12:19pm
Happy Valentines Day
me and my imaginary girlfriend 'athea' are having dinner tonite right Subaru1i.. wink ;) imaginary /-mj′-nr″/ adjective Hav ; unreal
...more
(615)
•••
okgonow
X
View Profile
View Bullboard History
Comment by
okgonow
on Feb 14, 2024 11:21am
RE:RE:RE:Financial
\ thanks!!
(137)
•••
subaru1
X
View Profile
View Bullboard History
Comment by
subaru1
on Feb 14, 2024 11:19am
RE:RE:Financial
Okgonow, i am going back to my hole and waiting the financial, that will speak, have a great time until the end of march.
(615)
•••
okgonow
X
View Profile
View Bullboard History
Comment by
okgonow
on Feb 14, 2024 11:11am
RE:Financial
oh my you crawled out of your hole again!!!!! by your assessment all those AI plays are pure speculation then because they all trade on forward earnings at many many multiples i would say that that
...more
(615)
•••
okgonow
X
View Profile
View Bullboard History
Comment by
okgonow
on Feb 14, 2024 11:07am
RE:RE:RE:DEA /U.S market.
woke up on the wrong side of the bed again today???? i know you dont like others asking reasonable questions that may even inform new investors in LABS you just keep all your deep analysys of LABS
...more
Prev
...
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >